News
June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...
The U.S. has approved the world's only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday.
5d
Interesting Engineering on MSNWorld’s first twice-a-year HIV prevention shot approved by FDA after 99.9% successThe United States has approved the world’s first twice-yearly HIV prevention shot, marking a major milestone in the ...
The US FDA has approved lenacapavir, a biannual injection by Gilead, to prevent HIV, potentially revolutionizing the fight against the epidemic.
Lenacapavir, the world's first twice-yearly HIV prevention shot, gets US FDA nod-offering a discreet, long-acting solution ...
The clearance ushers in a closely-watched launch for Gilead, which aims to show a long-acting injection can upend a market ...
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
The U.S. has approved the world’s only twice-a-year shot ... in HIV infections, while rates continued rising elsewhere. About half of new infections are in women, who often need protection ...
WASHINGTON D.C., DC — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first ... of new infections are in women, who often need protection they can use without ...
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step ... of new infections are in women, who often need protection they can use without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results